Biosimilars India 2011

Attend the 2nd Annual Biosimilars India 2011 from 14-15 July, Mumbai, to discover effective and implementable solutions to your regulatory, technical and commercialisation challenges. Take away practical strategies to ensure you capitalise on the host of opportunities available in the biosimilar market.

Register by 17 June and save INR 5,000 / US$100!

Expert speakers confirmed to share their unique insights and know-how include:

  • KK Tripathi, Adviser, Scientist ‘G’ and Member Secretary RCGM, Department of Biotechnology
  • Brij Patel, Deputy Manager, Biologicals and Biotechnology Unit, Medicines and Healthcare products Regulatory Agency, (MHRA)
  • Roger L Williams, Chief Executive Officer, US Pharmacopoeia
  • KV Subramaniam, President and Chief Executive Officer, Reliance Life Sciences
  • Ganesh Kumraj, President Operations, Bharat Serums and Vaccines
  • Cyrus Karkaria, President Biotech Division, Lupin Pharmaceuticals
  • Dhananjay Patankar, Vice President Biologics, Syngene International
  • Rustom Mody, Chief Scientific Officer, Intas Biopharmaceuticals
  • Matthias Jöhnck , Head of Merck Millipore Chromatography, Research and Development, Merck, Darmstadt
  • Anil Kukreja, Director Medical Affairs, Roche Products, India
  • Mahua Ganguly, Head Medical Affairs, Biogen Idec, India
  • Hareesh Parandhaman, Assistant Director Business Development, Lupin Pharmaceuticals

To secure your place at this essential event and to benefit from the early booking discount, call +91 (022) 4046 1466, email us at or visit

We look forward to welcoming you to a revised, refreshed and highly relevant event for the Indian biopharmaceutical industry.

Oby George
Programme Manager
CPhI Conferences

No comments: